Lori Kiefer, MD
Pain Medicine · Indianapolis, INNPI 1033352943
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Medtronic at 30.9% of the total. Reporting peaked in 2024 at $2,105 and has fallen 79.7% since, to $426 in 2025.
Across 82 payments — averaging $65.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Abbott$1K
- Curonix LLC$570
- Saluda Medical Americas, Inc.$431
- Boston Scientific$356
- Nevro Corp.$240
- plus $652 from 16 others
What the payments were for
- Travel & lodging$2,29643%
- Food & beverage$3,04357%
- Education$311%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 16 | $1,661 |
| Abbott | 16 | $1,461 |
| Curonix LLC | 5 | $570 |
| Saluda Medical Americas, Inc. | 11 | $431 |
| Boston Scientific | 5 | $356 |
| Nevro Corp. | 4 | $240 |
| SPR Therapeutics, Inc | 3 | $106 |
| MML US, Inc. | 2 | $98 |
| Vertos Medical, Inc. | 2 | $51 |
| Globus Medical | 2 | $49 |
| Si-bone, Inc. | 2 | $48 |
| Relievant Medsystems, Inc. | 1 | $47 |
| Scilex Pharmaceuticals Inc. | 2 | $43 |
| Averitas Pharma Inc. | 2 | $42 |
| Nalu Medical, Inc. | 1 | $33 |
| Merz Pharmaceuticals, LLC | 2 | $32 |
| Avanos Medical | 1 | $26 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Painteq LLC | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $14 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $14 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,370 in reported general payments places this provider in the 65th percentile of 128 pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 689 | $20,177 |
| Xtampza ErOxycodone Myristate | 20 | $13,374 |
| LinzessLinaclotide | 24 | $12,992 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 449 | $10,840 |
| BelbucaBuprenorphine Hcl | 14 | $6,992 |
| Buprenorphine | 20 | $6,389 |
| Naloxone Hcl | 48 | $3,582 |
| Oxycodone Hcl | 211 | $3,571 |
| Lidocaine | 45 | $3,166 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 17 | $1,715 |
| Gabapentin | 138 | $1,441 |
| Pregabalin | 80 | $1,032 |
| Diclofenac Sodium | 51 | $1,015 |
| Morphine Sulfate ErMorphine Sulfate | 24 | $512 |
| Duloxetine Hcl | 31 | $493 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $20 | $20,36634 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 128 pain medicine providers in Indiana.
Other pain medicine in Indianapolis
- John SwoffordIndianapolis$127K
- Philip ShumskyIndianapolis$27K
- Michael GoldbergIndianapolis$13K
- Thelma Green MackIndianapolis$11K
- Troy PfefferkornIndianapolis$8K
- Raheleh Rahimi DarabadIndianapolis$5K
- Ting WeiIndianapolis$5K
- Ahmed ElsahyIndianapolis$5K
- John KihlkenIndianapolis$4K
- Derron WilsonCarmel$616K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.